XXXX : clinicopathologic study of 20 cases in a single center.

@entity1 @entity5 @entity2622 @entity4153
PURPOSE: To investigate clinicopathologic findings of @entity1 with @entity4153 ( @entity4153 ), and evaluate their prognosis. METHODS: We retrospectively reviewed the medical records of 20 @entity1 with histologically confirmed @entity4153 treated between October 1996 and December 2004 at Asan Medical Center, Korea. The review included demographic data, pathologic findings, treatments, and outcomes. RESULTS: Of 1,358 invasive @entity2622 , the incidence of @entity4153 was 1.5%. Median age was 45.5 years. The clinical stages were Ib in 11, IIa in two, IIb in one, IIIa in one, IIIb in one, IVa in three and IVb in one. Fourteen @entity1 underwent radical hysterectomy. Ten @entity1 are alive and nine show no evidence of disease. Median overall survival was 77.0 months and 5-year overall survival rate was 50%. There was significant difference in overall survival with FIGO stage and @entity5 mass size. CONCLUSION: Advanced FIGO stage and @entity5 mass size are poor prognostic factors for overall survival in @entity1 with @entity4153 . Even though @entity4153 is a highly aggressive @entity5 , early diagnosis and combined therapeutic modalities may lead to longer survival in some @entity1 .
